TRIM24 and dermatomyositis: Similarly, unsupervised clustering of gene expression data generated using the NanoString® nCounter PanCancer Immune Profiling PanelTM stratified anti-TIF1 and anti-Mi-2 positive DM patients, and identified a type I IFN signature in anti-Mi-2 muscle biopsy samples (51).